Related Articles
A review of advances & potential of applying nanomaterials for biofilm inhibition
Biofilms pose significant challenges due to their role in biological contamination and water quality damage. This review explores physical/chemical strategies for controlling biofilms, emphasizing the potential of nanomaterials to enhance antibiofilm performance. Popular characterization methods in biofilm studies are summarized in two aspects, bactericidal monitoring, and anti-adhesion monitoring, which serve as a toolbox for future studies. The insights provided are crucial for advancing biofilm management in various fields.
Optical sorting: past, present and future
Optical sorting combines optical tweezers with diverse techniques, including optical spectrum, artificial intelligence (AI) and immunoassay, to endow unprecedented capabilities in particle sorting. In comparison to other methods such as microfluidics, acoustics and electrophoresis, optical sorting offers appreciable advantages in nanoscale precision, high resolution, non-invasiveness, and is becoming increasingly indispensable in fields of biophysics, chemistry, and materials science. This review aims to offer a comprehensive overview of the history, development, and perspectives of various optical sorting techniques, categorised as passive and active sorting methods. To begin, we elucidate the fundamental physics and attributes of both conventional and exotic optical forces. We then explore sorting capabilities of active optical sorting, which fuses optical tweezers with a diversity of techniques, including Raman spectroscopy and machine learning. Afterwards, we reveal the essential roles played by deterministic light fields, configured with lens systems or metasurfaces, in the passive sorting of particles based on their varying sizes and shapes, sorting resolutions and speeds. We conclude with our vision of the most promising and futuristic directions, including AI-facilitated ultrafast and bio-morphology-selective sorting. It can be envisioned that optical sorting will inevitably become a revolutionary tool in scientific research and practical biomedical applications.
Design of functional and stable adhesion systems using reversible and movable crosslinked materials
Stable, tough, and functional adhesion systems are urgently needed for a sustainable society. As a resolution, supramolecular scientists have introduced reversible and movable crosslinked materials into adhesion systems. Reversible crosslinks can repeatedly associate and dissociate. Therefore, reversible crosslinked materials show self-healing and stimuli-responsive properties. Moreover, movable crosslinks are topological crosslinks in which the polymer chains penetrate the cavities of cyclic molecules. The sliding of the movable crosslinks with deformation enabled the achievement of materials showing high toughness and self-relaxation. Adhesion systems with reversible and movable crosslinks have improved adhesion and cohesion, stability, and functionality. This novel concept for the design of adhesion systems is expected to increase the lifetime of adhesives and ameliorate environmental problems.
Landscape of small nucleic acid therapeutics: moving from the bench to the clinic as next-generation medicines
The ability of small nucleic acids to modulate gene expression via a range of processes has been widely explored. Compared with conventional treatments, small nucleic acid therapeutics have the potential to achieve long-lasting or even curative effects via gene editing. As a result of recent technological advances, efficient small nucleic acid delivery for therapeutic and biomedical applications has been achieved, accelerating their clinical translation. Here, we review the increasing number of small nucleic acid therapeutic classes and the most common chemical modifications and delivery platforms. We also discuss the key advances in the design, development and therapeutic application of each delivery platform. Furthermore, this review presents comprehensive profiles of currently approved small nucleic acid drugs, including 11 antisense oligonucleotides (ASOs), 2 aptamers and 6 siRNA drugs, summarizing their modifications, disease-specific mechanisms of action and delivery strategies. Other candidates whose clinical trial status has been recorded and updated are also discussed. We also consider strategic issues such as important safety considerations, novel vectors and hurdles for translating academic breakthroughs to the clinic. Small nucleic acid therapeutics have produced favorable results in clinical trials and have the potential to address previously “undruggable” targets, suggesting that they could be useful for guiding the development of additional clinical candidates.
Recruitment of apolipoprotein E facilitates Herpes simplex virus 1 attachment and release
Human apolipoprotein E (ApoE) has been shown to play important roles during primary infection and pathogenesis of several viruses. Furthermore, epidemiological studies suggest that interactions between ApoE 4 and herpes simplex virus type-1 (HSV1) could associate with higher risk of Alzheimer’s disease. Nevertheless, little is known about the ApoE-HSV1 interactions at molecular levels. Here, we investigate the effects of ApoE on HSV1 infection in vitro. Our results show that ApoE promotes HSV1 growth, which is attributed to the incorporation of ApoE into HSV1 particles. Using both biological and biophysical approaches, we conclude that ApoE-coated HSV1 demonstrates a more efficient attachment to and faster release from the cell surface. Mechanistic studies reveal that ApoE modifies HSV1 interactions with heparan sulfate, thereby modulating interactions between HSV1 and the cell surface. Overall, our results provide new insights into the roles of ApoE during HSV1 infections which may inspire future studies on Alzheimer’s disease etiology.
Responses